Zehong Zhou, Rong Li, Jie Qiao Reproductive BioMedicine Online

Slides:

Advertisements

Similar presentations

J. Ben-Nagi, J. Miell, D. Mavrelos, J. Naftalin, C. Lee, D. Jurkovic

Advertisements

Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS Bulent O Yildiz, Gurkan Bozdag, Umit Otegen, Ayla Harmanci,

Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C) Michael W. Pankhurst,

J.C. Sadeu, A.M.C.M. Doedée, M.S. Neal, E.G. Hughes, W.G. Foster

Hatem Abu Hashim Reproductive BioMedicine Online

Donghong He, Fengyan Jiang Reproductive BioMedicine Online

Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome Ahmed M. Mohamadin, Fawzia A. Habib, Thoraya.

Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome Nadine M.P. Daan, M.D.,

External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients Scott M.

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial Malin Nylander, Signe Frøssing, Helle V. Clausen,

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles Ze Wu, Rong Li, Yanping Ma, Bo Deng,

Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome Elisabeth Lerchbaum,

Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate Claus Yding Andersen,

Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis Annelies Overbeek, Frank J. Broekmans, Wouter.

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters Enrico Carmina, M.D., Francesco.

MiR-483–5p and miR-486–5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome Lin Shi, Shan Liu, Wanqiu.

A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C

S. Rahlenbeck, W. Mekonnen, Y. Melkamu Reproductive BioMedicine Online

Cornelia van Zyl, Maretha J. Visser Reproductive BioMedicine Online

Low aneuploidy rate in early pregnancy loss abortuses from patients with polycystic ovary syndrome Qiong Wang, Lu Luo, Qiong Lei, Ming-Mei Lin, Xuan.

Amir Wiser, Einat Shalom-Paz, Jordana H

Gillian M. Lockwood Reproductive BioMedicine Online

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels

Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of.

Why are reproductive cancers more common in nulliparous women?

E.A.M. Kuijper, J.C.F. Ket, M.R. Caanen, C.B. Lambalk

K. Gersak, A. Veble Reproductive BioMedicine Online

Anthropometric indices to predict insulin resistance in women with polycystic ovary syndrome in China Tingting Liu, Qiuyi Wang, Wei Huang, Jing Tan,

Utility of age-specific serum anti-Müllerian hormone concentrations

S Munné, E Fragouli, P Colls, MG Katz-Jaffe, WB Schoolcraft, D Wells

Sarah McCredie, William Ledger, Christos A. Venetis

Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study A. Nasr Reproductive BioMedicine Online

J. Ben-Nagi, J. Miell, D. Mavrelos, J. Naftalin, C. Lee, D. Jurkovic

Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome.

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Polycystic ovary syndrome: analysis of the global research architecture using density equalizing mapping Dörthe Brüggmann, Lea Berges, Doris Klingelhöfer,

Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis Juan Gui, Rui-hao Wang Reproductive.

Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational.

Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF Kirsty.

Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter Hongcui.

Multifetal pregnancy reduction of triplets to twins compared with non-reduced triplets: a meta-analysis Yaniv Zipori, Jigal Haas, Howard Berger, Eran.

Mutational analysis of TOX3 in Chinese Han women with polycystic ovary syndrome Yuqian Cui, Shigang Zhao, Han Zhao, Yue Lv, Mengru Yu, Yu Wang, Zi-Jiang.

Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis Shiqin Zhu, M.D., Bingqian Zhang, M.D.,

Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction Kathrine Birch Petersen, Nina Gros Pedersen, Anette.

Is polycystic ovary syndrome a sexual conflict? A review

Should we be promoting embryo transfer at blastocyst stage?

Stephen C. Collins, Esther Chan Reproductive BioMedicine Online

Pietro Gambadauro, Ramesan Navaratnarajah

Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease Suleyman Guven, S Caner Karahan,

Serum inhibin A concentration in women with polycystic ovarian syndrome and the correlation to ethnicity, androgens and insulin resistance Shimon Segal,

Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome Macarena Alpañés, M.D., Manuel.

Testosterone concentrations in early pregnancy: relation to method of conception in an infertile population Ruth B. Lathi, Sharon E. Moayeri, Charitha.

Elective single-embryo transfer: persuasive communication strategies can affect choice in a young British population O.B.A. van den Akker, S. Purewal

Progesterone elevation on the day of HCG administration may affect rescue ICSI Bo Huang, Zhou Li, Lixia Zhu, Dan Hu, Qun Liu, Guijin Zhu, Hanwang Zhang

Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study Kok-Min Seow, Yieh-Loong Tsai, Chi-Chang.

How common is polycystic ovary syndrome in recurrent miscarriage?

Ovarian reserve screening before contraception?

Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome Peiwen Liang, M.D., Liuqing Xi,

ACC/AHA 2017 definition of high blood pressure: implications for women with polycystic ovary syndrome Lucas Bandeira Marchesan, B.Sc., Poli Mara Spritzer,

Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women.

Nicole A. Huijgen, Yvonne V. Louwers, Sten P. Willemsen, Jeanne H. M

Paolo Moghetti, M.D. Fertility and Sterility

China’s model of egg donation is a policy lesson for Britain

Fertility in cancer patients after cryopreservation of one ovary

Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome Kevin H. Maas, M.D., Ph.D., Sandy Chuan,

Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome Basak Yildirim, M.D., Nuran Sabir,

Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels

Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M

Polycystic Ovary Syndrome (PCOS)

Enrico Carmina, M.D., Rogerio A Lobo, M.D. Fertility and Sterility

Presentation transcript:

Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years Zehong Zhou, Rong Li, Jie Qiao Reproductive BioMedicine Online Volume 35, Issue 3, Pages 331-339 (September 2017) DOI: 10.1016/j.rbmo.2017.05.019 Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 Participants in this investigation. PCOS, polycystic ovary syndrome. Reproductive BioMedicine Online 2017 35, 331-339DOI: (10.1016/j.rbmo.2017.05.019) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 Median, the first and third quartile of the free androgen index and concentrations of total testosterone, androstenedione and sex hormone-binding globulin in different age groups of the polylcystic ovary syndrome (n = 833) and ‘healthy’ reference (n = 821) populations. P-median, median of the values in the PCOS population; Re-median, median of the values in the ‘healthy’ reference population. Reproductive BioMedicine Online 2017 35, 331-339DOI: (10.1016/j.rbmo.2017.05.019) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions

Figure 3 The prevalence of endocrine and metabolic disorders in the hyperandrogenaemia (n = 288) and non- hyperandrogenaemia (n = 2444) groups defined by the value of 6.0 for free androgen index among the control population. H-A4, androstenedione over 10.8 nmol/l; IR, insulin resistance; central obesity, WHR ≥0.80; L-HDL, low level of serum high-density lipoprotein-cholesterol (HDL-C) < 1.3 mmol/l; MI, menstrual irregularity; PCOM, polycystic ovary morphology; MS, metabolic syndrome; HBP, hypertension; FL, fatty liver. *, Statistically significant differences between the hyperandrogenaemia and non- hyperandrogenaemia group (P < 0.001). Reproductive BioMedicine Online 2017 35, 331-339DOI: (10.1016/j.rbmo.2017.05.019) Copyright © 2017 Reproductive Healthcare Ltd. Terms and Conditions